HeraMED (ASX:HMD) has raised US$2.8 million via placement and SPP
HeraMED Limited (ASX:HMD) has raised funds to accelerate HearCARE’s commercial roll out and progress ongoing research projects.
HeraMED is a medical technology company leading the digital transformation of maternity care with its proprietary telehealth platform. The company offers a platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, big data and a digital social networking dashboard.
Oaklins’ team in Australia acted as lead manager in this transaction.
Talk to the deal team
Related deals
Xeros Technology Group has completed a placing, subscription and retail offer
Xeros Technology Group plc has raised funds to drive forward its commercialization strategy.
Learn moreInfotreasury has been sold to Matera
Matera, a leading banking software company with world-class instant payments and core banking solutions, has acquired Infotreasury.
Learn moreFairness opinion provided to the independent Board members of Orange Belgium
The independent Board members of Orange Belgium have received a fairness opinion in the context of a contribution in-kind of VOO shares in Orange Belgium.
Learn more